CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 85 filers reported holding CHINOOK THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $46,978,295 | -11.6% | 2,029,300 | 0.0% | 0.92% | -9.3% |
| Q4 2022 | $53,167,660 | +33.3% | 2,029,300 | 0.0% | 1.02% | +37.2% |
| Q3 2022 | $39,896,000 | +20.3% | 2,029,300 | +7.0% | 0.74% | +23.3% |
| Q2 2022 | $33,166,000 | +42.9% | 1,896,300 | +33.7% | 0.60% | +59.8% |
| Q1 2022 | $23,203,000 | +0.3% | 1,418,300 | 0.0% | 0.38% | +26.6% |
| Q4 2021 | $23,132,000 | +27.6% | 1,418,300 | -0.2% | 0.30% | +49.2% |
| Q3 2021 | $18,127,000 | -3.7% | 1,420,637 | +6.5% | 0.20% | +4.7% |
| Q2 2021 | $18,833,000 | -3.0% | 1,333,801 | +6.7% | 0.19% | +4.4% |
| Q1 2021 | $19,425,000 | -2.0% | 1,250,001 | 0.0% | 0.18% | +5.2% |
| Q4 2020 | $19,825,000 | – | 1,250,001 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 3,168,388 | $49,237,000 | 9.08% |
| ATP Life Science Ventures, L.P. | 4,028,937 | $62,610,000 | 6.97% |
| Affinity Asset Advisors, LLC | 175,000 | $2,720,000 | 0.92% |
| Altium Capital Management LP | 205,799 | $3,198,000 | 0.89% |
| EcoR1 Capital, LLC | 1,250,001 | $19,425,000 | 0.86% |
| Vivo Capital, LLC | 1,206,266 | $18,745,000 | 0.66% |
| Rubric Capital Management LP | 325,863 | $5,064,000 | 0.30% |
| Rock Springs Capital Management LP | 673,049 | $10,459,000 | 0.23% |
| Orbimed Advisors | 1,250,001 | $19,425,000 | 0.18% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 549,615 | $8,541,000 | 0.13% |